{
    "2021-03-26": [
        [
            {
                "time": "",
                "original_text": "抗疫一周年公益再出发 复星医疗加快“硬核”科技打造健康管理平台",
                "features": {
                    "keywords": [
                        "抗疫",
                        "复星医疗",
                        "硬核科技",
                        "健康管理平台"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "健康科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-03-26",
                "original_text": "智通港股通持股分析 | 3月26日",
                "features": {
                    "keywords": [
                        "港股通",
                        "持股分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "协和发酵麒麟布罗索尤单抗新适应证获批；和黄医药1.69亿美元出售非处方药合资企业；复星医药新冠疫苗暂停港澳地区接种",
                "features": {
                    "keywords": [
                        "协和发酵麒麟",
                        "布罗索尤单抗",
                        "和黄医药",
                        "非处方药",
                        "复星医药",
                        "新冠疫苗",
                        "港澳地区"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}